Brief: Basilea Pharmaceutica Announce Sales Performance Of Cresemba® Exceeded Threshold Triggering USD 5 Mln Milestone Payment

Basilea Pharmaceutica AG, Allschwil

09/02/2026 06:21

Feb 9 (Reuters) - BASILEA PHARMACEUTICA AG ALLSCHWIL BSLN.S:

STRONG CRESEMBA® (ISAVUCONAZOLE) SALES PERFORMANCE IN ASIA PACIFIC AND CHINA TRIGGERS MILESTONE PAYMENT TO BASILEA

ANNOUNCED TODAY THAT CONTINUED STRONG SALES PERFORMANCE OF ANTIFUNGAL CRESEMBA® EXCEEDED SALES THRESHOLD TRIGGERING A USD 5 MILLION MILESTONE PAYMENT

Source text: ID:nGNE114w7S

Further company coverage: BSLN.S

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 587785269;))